SunHealth Therapeutics

Humans developed an internal cannabinoid system about 400 million years ago. The recently discovered purpose of the Endocannabinoid System (ECS) was to help stabilize individual organ systems to keep them healthy far before medicines and doctors were available. The organ systems contain numerous receptors and distinct from each other. When disease strikes an organ system, deterioration occurs far past the capability of the ECS. Disease states can initiate or, be influenced by; genetic, environmental or psychological factors. More specifically, the ECS activation system is highly orchestrated requiring many biochemical agonists and antagonists working in sequences for it to work at it’s best.

Partial response and defense to many diseases involve the integrity of the ECS. We now know that many cannabinoids can support the ECS without the need for the psychoactive molecule THC. This allows formulations to be developed without the need for a medical marijuana license. Hence, hemp plant derived cannabinoids, along with terpenes can offer a solution to patients with these diseases.

The goal of SunHealth Therapeutics is to develop and offer unique combinations of hemp derived cannabinoids and terpenes to help stabilize these organ systems and therefore, help provide relief and improved quality of life. These products have been matched through the most recent clinical information and medical research to provide the best possible care. You, the patient, now have this highly specific advanced medical cannabis option available.

Our Mission Statement is to help patients relieve their symptoms, improve their quality of life and comfort when possible.